Phase 2a Study to Evaluate Optimum Dosage and Stability of DW-3101 in Gastric Inflammation Patients
Status:
Unknown status
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to find optimum dosage of DW-3101 by evaluating efficacy and
safety of each dosage group in Korean patients with acute and chronic gastric inflammation.